Evidence map›Paper›PMID 28332140›Full record

ReviewCurrent reviews in musculoskeletal medicine2017

Interspinous implants: are the new implants better than the last generation? A review.

Michael Pintauro, Alexander Duffy, Payman Vahedi, George Rymarczuk, Joshua Heller

Open access · bronzeAbstract readReview
In one paragraph

Review in Current reviews in musculoskeletal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Axial loading during MRI reveals insufficient effect of percutaneous interspinous implants (Aperius™ PerCLID™) on spinal canal area.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael PintauroDepartment of Neurological Surgery, Thomas Jefferson University, 909 Walnut St, 3rd Floor, COB Bldg, Philadelphia, PA, 19107, USA.
Alexander DuffyDepartment of Neurological Surgery, Thomas Jefferson University, 909 Walnut St, 3rd Floor, COB Bldg, Philadelphia, PA, 19107, USA.
Payman VahediDepartment of Neurological Surgery, Thomas Jefferson University, 909 Walnut St, 3rd Floor, COB Bldg, Philadelphia, PA, 19107, USA. payman.vahedi@gmail.com.
George RymarczukDepartment of Neurological Surgery, Thomas Jefferson University, 909 Walnut St, 3rd Floor, COB Bldg, Philadelphia, PA, 19107, USA.
Joshua HellerDepartment of Neurological Surgery, Thomas Jefferson University, 909 Walnut St, 3rd Floor, COB Bldg, Philadelphia, PA, 19107, USA.
Neurological Surgery · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewInterspinous process devices (IPDs) are used in the surgical treatment of lumbar spinal stenosis. The purpose of this review is to compare the first generation with the next-generation devices in terms of complications, device failure, reoperation rates, symptom relief, and outcome. RECENT

findingsThirty-seven studies were included from 2011 to 2016. Device failure occurred at a mean of 3.7%, with a lower tendency to happen with next-generation IPDs. Reoperations occurred at a lower rate with the next-generation devices, with a mean follow up of 24 months (3.7% vs. 11.1%). The clinical outcome is not influenced by the type of IPD. The long-term functionality of these devices is questionable, with radiologic changes and recurrence of symptoms often seen by 2 years following implantation. Next-generation devices do not appear to be subject to the same "bounce back" effect of symptom re-emergence after several years.

Indexed as

Canal stenosisCoflexInterspinous deviceLumbarSpineX-Stop

Identifiers

PMID28332140
PMCPMC5435632
OpenAlexW2603423361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.